A Study of Seltorexant in Participants With Probable Alzheimer's Disease
Clinical trial NCT05307692 · COMPLETED
Trial details
- NCT number
- NCT05307692
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2023-11-10
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.